Last reviewed · How we verify
Z7200
At a glance
| Generic name | Z7200 |
|---|---|
| Also known as | Test product |
| Sponsor | Zambon SpA |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers (PHASE1)
- Clinical Study to Evaluate Z7200 Pharmacokinetics Profile (PHASE1)
- Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Z7200 CI brief — competitive landscape report
- Z7200 updates RSS · CI watch RSS
- Zambon SpA portfolio CI